Evidence map›Paper›PMID 35508395›Full record

ArticleNeurology2022

Factors Predicting Outcome After Intracranial EEG Evaluation in Patients With Medically Refractory Epilepsy.

Adithya Sivaraju, Lawrence Hirsch, Nicolas Gaspard, Pue Farooque, Jason Gerrard, Yunshan Xu, Yanhong Deng, Eyiyemisi Damisah, Hal Blumenfeld, Dennis D Spencer

Open access · greenAbstract read
In one paragraph

Article in Neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Adithya SivarajuFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT. adithya.sivaraju@yale.edu.ORCID 0000-0002-6027-9205
Lawrence HirschFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.ORCID 0000-0002-6333-832X
Nicolas GaspardFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Pue FarooqueFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Jason GerrardFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Yunshan XuFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Yanhong DengFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Eyiyemisi DamisahFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.ORCID 0000-0001-8854-1335
Hal BlumenfeldFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Dennis D SpencerFrom the Comprehensive Epilepsy Center (A.S., L.H., N.G., P.F., H.B.), Department of Neurology, Yale University School of Medicine, New Haven, CT; Service de Neurologie (N.G.), Université Libre de Bruxelles-Hôpital Erasme, Belgium; Comprehensive Epilepsy Center (J.G., E.D., D.D.S.), Department of Neurosurgery, Yale University School of Medicine, New Haven; and Yale Center for Analytical Sciences (Y.X., Y.D.), Yale School of Public Health, New Haven, CT.
Yale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

BACKGROUND AND

objectivesThe aim of this study was to identify predictors of a resective surgery and subsequent seizure freedom following intracranial EEG (ICEEG) for seizure-onset localization.

methodsThis is a retrospective chart review of 178 consecutive patients with medically refractory epilepsy who underwent ICEEG monitoring from 2002 to 2015. Univariable and multivariable regression analysis identified independent predictors of resection vs other options. Stepwise Akaike information criteria with the aid of clinical consideration were used to select the best multivariable model for predicting resection and outcome. Discrete time survival analysis was used to analyze the factors predicting seizure-free outcome. Cumulative probability of seizure freedom was analyzed using Kaplan-Meier curves and compared between resection and nonresection groups. Additional univariate analysis was performed on 8 select clinical scenarios commonly encountered during epilepsy surgical evaluations.

resultsMultivariable analysis identified the presence of a lesional MRI, presurgical hypothesis suggesting temporal lobe onset, and a nondominant hemisphere implant as independent predictors of resection ( DISCUSSION: Unfavorable predictors, including having nonlesional extratemporal epilepsy, should not deter a thorough presurgical evaluation, including with invasive recordings in many cases. Resective surgery without functional impairment offers the best chance for sustained seizure freedom and should always be considered first. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that the presence of a lesional MRI, presurgical hypothesis suggesting temporal lobe onset, and a nondominant hemisphere implant are independent predictors of resection. Focal ICEEG onset and undergoing resection are independent predictors of 5-year seizure freedom.

Indexed as

Drug Resistant EpilepsyElectrocorticographyElectroencephalographyHumansMagnetic Resonance ImagingRetrospective StudiesTreatment Outcome

Identifiers

PMID35508395
PMCPMC9259091
OpenAlexW4229017746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.